William Annett joined OncoCyte as Chief Executive Officer in June 2015. Mr. Annett’s diagnostics industry experience includes his service as CEO of BioFX Laboratories, Inc., an in vitro diagnostic company successfully sold to a large life sciences company. He founded and led Corra Life Sciences, a prenatal diagnostics company focused on diagnosis of the major diseases of pregnancy. Mr. Annett also founded a consumer products company, which became publicly traded on NASDAQ, during his six-year tenure as CEO, and then acquired. At Genentech, Mr. Annett led the Commercial Strategy group, managed large operational projects with several hundred team members, and directed the Project Finance function, which supported all pipeline products with more than 200 clinical trials. Most recently, Mr. Annett was a Managing Director at Accenture where he headed the West Coast Life Sciences practice with sales, marketing, and delivery responsibilities. He holds an MBA from the Harvard Business School.